These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 11744689)
21. Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation. Li S; Moy L; Pittman N; Shue G; Aufiero B; Neufeld EJ; LeLeiko NS; Walsh MJ J Biol Chem; 1999 Mar; 274(12):7803-15. PubMed ID: 10075672 [TBL] [Abstract][Full Text] [Related]
22. Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota. Chuang LY; Guh JY; Liu SF; Hung MY; Liao TN; Chiang TA; Huang JS; Huang YL; Lin CF; Yang YL Biochem J; 2003 Oct; 375(Pt 2):385-93. PubMed ID: 12841849 [TBL] [Abstract][Full Text] [Related]
23. Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells. Su M; Bansal AK; Mantovani R; Sodek J J Biol Chem; 2005 Nov; 280(46):38365-75. PubMed ID: 16087680 [TBL] [Abstract][Full Text] [Related]
25. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478 [TBL] [Abstract][Full Text] [Related]
26. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884 [TBL] [Abstract][Full Text] [Related]
27. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II. Song K; Krebs TL; Danielpour D J Biol Chem; 2006 Mar; 281(12):7765-74. PubMed ID: 16428382 [TBL] [Abstract][Full Text] [Related]
28. PARP regulates TGF-beta receptor type II expression in estrogen receptor-positive breast cancer cell lines. Sterling JA; Wu L; Banerji SS Anticancer Res; 2006; 26(3A):1893-901. PubMed ID: 16827122 [TBL] [Abstract][Full Text] [Related]
29. Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter. Mehra-Chaudhary R; Matsui H; Raghow R Biochem J; 2001 Jan; 353(Pt 1):13-22. PubMed ID: 11115394 [TBL] [Abstract][Full Text] [Related]
30. Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells. Kelly D; Kim SJ; Rizzino A J Biol Chem; 1998 Aug; 273(33):21115-24. PubMed ID: 9694866 [TBL] [Abstract][Full Text] [Related]
31. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine. Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722 [TBL] [Abstract][Full Text] [Related]
33. CCAAT/enhancer-binding protein alpha (C/EBPalpha) activates transcription of the human microsomal epoxide hydrolase gene (EPHX1) through the interaction with DNA-bound NF-Y. Zhu QS; Qian B; Levy D J Biol Chem; 2004 Jul; 279(29):29902-10. PubMed ID: 15150264 [TBL] [Abstract][Full Text] [Related]
34. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707 [TBL] [Abstract][Full Text] [Related]
35. Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. Martin D; Tawadros T; Meylan L; Abderrahmani A; Condorelli DF; Waeber G; Haefliger JA J Biol Chem; 2003 Dec; 278(52):53082-9. PubMed ID: 14565956 [TBL] [Abstract][Full Text] [Related]
36. The histone deacetylase inhibitor trichostatin A induces GADD45 gamma expression via Oct and NF-Y binding sites. Campanero MR; Herrero A; Calvo V Oncogene; 2008 Feb; 27(9):1263-72. PubMed ID: 17724474 [TBL] [Abstract][Full Text] [Related]
37. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D; Masri S; Ye JJ; Chen S Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749 [TBL] [Abstract][Full Text] [Related]
38. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways. Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219 [TBL] [Abstract][Full Text] [Related]
39. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164 [TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]